Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00726_DB01241_nanopub.RAq1lxZNsEHj_aAjGEEv-1XqPh3AWqjel4Z2Pwj7G1tB4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00726_DB01241 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB01241 label "DDI between Trimipramine and Gemfibrozil - The strong CYP2C19 inhibitor, Gemfibrozil, may decrease the metabolism and clearance of Trimipramine, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Gemfibrozil is initiated, discontinued or dose changed. [drugbank_resource:DB00726_DB01241]" assertion.
- drugbank_resource:DB00726_DB01241 identifier "drugbank_resource:DB00726_DB01241" assertion.
- drugbank_resource:DB00726_DB01241 title "DDI between Trimipramine and Gemfibrozil - The strong CYP2C19 inhibitor, Gemfibrozil, may decrease the metabolism and clearance of Trimipramine, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Gemfibrozil is initiated, discontinued or dose changed." assertion.
- drugbank:DB01241 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01241 assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01241 assertion.